Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.
Klebsiella pneumoniae serotype 1 and serotype 2 and their capsular variants were examined for production of cell-associated capsular polysaccharides and extracellular capsular polysaccharides. The virulence of these organisms in experimental animals was examined via intraperitoneal injection in mice and transtracheal inoculation into the lungs of rats. It was found that the production of either polysaccharide component correlated with the observed virulence. The extracellular polysaccharides were purified by ethanol precipitation, electrodialysis, extraction with quaternary ammonium salts, and gel filtration. These purification steps allowed for the separation and purification of both the extracellular lipopolysaccharide and the extracellular capsular polysaccharide. Purified extracellular capsular polysaccharide and extracellular lipopolysaccharide were co-injected with K. pneumoniae intraperitoneally into mice to determine if either of these substances would produce an effect on the natural course of infection in these animals. These studies showed that only purified extracellular lipopolysaccharide enhanced the virulence of K. pneumoniae when co-injected into mice, and this virulence enhancement correlated with the content of extracellular lipopolysaccharide, but not extracellular capsular polysaccharide in mixtures of these polysaccharides. Saponification of K. pneumoniae serotype 1 extracellular polysaccharides significantly decreased their virulence-enhancing capabilities in mice, further suggesting that extracellular lipopolysaccharide may play a role in these infections.
D000818:Animals; D011232:Chemical Precipitation; D002847:Chromatography, Agarose; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D004195:Disease Models, Animal; D007710:Klebsiella Infections / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000378:metabolism / Q000472:pathogenicity*; D008070:Lipopolysaccharides / Q000302:isolation & purification / Q000494:pharmacology; D051379:Mice; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis / Q000302:isolation & purification / Q000502:physiology*; D051381:Rats; D014774:Virulence
D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial